Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?

By Basso D.   Fogar P.   Piva M.G.   Navaglia F.   Mazza S.   Prayer-Galetti T.   Castellucci E.   Pagano F.   Plebani M.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 710-715

Elsevier

Access to resources Recommend Favorite

Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection

By Tanguay S.   Begin L.R.   Elhilali M.M.   Behlouli H.   Karakiewicz P.I.   Aprikian A.G.  

Urology, Vol. 59, Iss. 2, 2002-02 ,pp. : 261-265

Elsevier

Access to resources Recommend Favorite

Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection

By Taneja S.S.   Tran K.   Lepor H.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 222-226

Elsevier

Access to resources Recommend Favorite

Complexed PSA performance for prostate cancer detection in an African-American population

By Martin B.   Cheli C.D.   Lifsey D.   Ward M.   Pollard S.   Jefferson L.   Thiel R.P.   Rayford W.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 835-839

Elsevier

Access to resources Recommend Favorite

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

By Djavan B.   Zlotta A.   Kratzik C.   Remzi M.   Seitz C.   Schulman C.C.   Marberger M.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 517-522

Elsevier

Access to resources Recommend Favorite